GB201705491D0 - Intelligent delivery of ingested and absorbed molecules - Google Patents

Intelligent delivery of ingested and absorbed molecules

Info

Publication number
GB201705491D0
GB201705491D0 GBGB1705491.7A GB201705491A GB201705491D0 GB 201705491 D0 GB201705491 D0 GB 201705491D0 GB 201705491 A GB201705491 A GB 201705491A GB 201705491 D0 GB201705491 D0 GB 201705491D0
Authority
GB
United Kingdom
Prior art keywords
ingested
intelligent delivery
absorbed molecules
absorbed
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1705491.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immd Sp Zo O
Original Assignee
Immd Sp Zo O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immd Sp Zo O filed Critical Immd Sp Zo O
Priority to GBGB1705491.7A priority Critical patent/GB201705491D0/en
Publication of GB201705491D0 publication Critical patent/GB201705491D0/en
Priority to US16/346,955 priority patent/US11696920B2/en
Priority to PCT/EP2017/078242 priority patent/WO2018083271A1/en
Priority to EP17800452.9A priority patent/EP3534884A1/en
Priority to CN201780082689.9A priority patent/CN110198706A/en
Priority to BR112019008739A priority patent/BR112019008739A2/en
Priority to CA3042592A priority patent/CA3042592A1/en
Priority to JP2019545865A priority patent/JP2019534329A/en
Priority to IL266385A priority patent/IL266385A/en
Priority to US18/207,893 priority patent/US20230310470A1/en
Ceased legal-status Critical Current

Links

GBGB1705491.7A 2016-11-04 2017-04-05 Intelligent delivery of ingested and absorbed molecules Ceased GB201705491D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1705491.7A GB201705491D0 (en) 2017-04-05 2017-04-05 Intelligent delivery of ingested and absorbed molecules
JP2019545865A JP2019534329A (en) 2016-11-04 2017-11-03 Intelligent delivery of ingested and absorbed molecules
CN201780082689.9A CN110198706A (en) 2016-11-04 2017-11-03 The intelligent delivery of intake and absorption molecule
PCT/EP2017/078242 WO2018083271A1 (en) 2016-11-04 2017-11-03 Inteligent delivery of ingested and absorbed molecules
EP17800452.9A EP3534884A1 (en) 2016-11-04 2017-11-03 Intelligent delivery of ingested and absorbed molecules
US16/346,955 US11696920B2 (en) 2016-11-04 2017-11-03 Intelligent delivery of ingested and absorbed molecules
BR112019008739A BR112019008739A2 (en) 2016-11-04 2017-11-03 intelligent distribution of ingested and absorbed molecules
CA3042592A CA3042592A1 (en) 2016-11-04 2017-11-03 Inteligent delivery of ingested and absorbed molecules
IL266385A IL266385A (en) 2016-11-04 2019-05-01 Intelligent delivery of ingested and absorbed molecules
US18/207,893 US20230310470A1 (en) 2016-11-04 2023-06-09 Intelligent delivery of ingested and absorbed molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1705491.7A GB201705491D0 (en) 2017-04-05 2017-04-05 Intelligent delivery of ingested and absorbed molecules

Publications (1)

Publication Number Publication Date
GB201705491D0 true GB201705491D0 (en) 2017-05-17

Family

ID=58682706

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1705491.7A Ceased GB201705491D0 (en) 2016-11-04 2017-04-05 Intelligent delivery of ingested and absorbed molecules

Country Status (1)

Country Link
GB (1) GB201705491D0 (en)

Similar Documents

Publication Publication Date Title
HUS2400014I1 (en) Therapeutic antibodies and their uses
ZA201907815B (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
IL267822B1 (en) Infusion system and components thereof
EP3212221A4 (en) Efficient delivery of therapeutic molecules in vitro and in vivo
EP3204032A4 (en) Efficient delivery of therapeutic molecules in vitro and in vivo
GB201519858D0 (en) Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
HK1254602A1 (en) Infusion system and components thereof
IL262251A (en) New anti-sirpa antibodies and their therapeutic applications
DK3335739T3 (en) Mussel adhesive protein product and the use thereof for the treatment of inflammation of the mucosa
HK1217720A1 (en) Selective delivery molecules and methods of use
HK1247091A1 (en) Therapeutic antibodies and uses thereof
IL284236A (en) Modifications and uses of conotoxin peptides
IL266385A (en) Intelligent delivery of ingested and absorbed molecules
PL3228313T3 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
GB201705491D0 (en) Intelligent delivery of ingested and absorbed molecules
AU2013902497A0 (en) Treatment and prevention of mastitis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)